MRSN — Mersana Therapeutics Share News
0.000.00%
Last trade - 00:00- $145.16m
- $88.77m
- $40.50m
NASDAQ RESUMED AT 10:03 AM
NASDAQ RESUMED AT 10:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 10:00 AM
Brief: Day One Completes Acquisition Of Mersana Therapeutics
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:46 AM
NASDAQ RESUMED AT 09:46 AM
NASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:35 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:05 AM
NASDAQ RESUMED AT 09:05 AM
NASDAQ RESUMED AT 04:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Nasdaq biotech index hits record high, set to gain nearly 5% this week
Mersana Therapeutics Q3 loss widens
Brief: Mersana Therapeutics Q3 EPS USD -1.51
U.S. RESEARCH ROUNDUP-Disney, Enanta Pharmaceuticals, Phillips 66
U.S. STOCKS ON THE MOVE-Broadwind, Verizon, APA